Charles River CEO says it likely won’t be the last manufacturer to break away from cell and gene therapy

Three months ago, Charles River Laboratories announced it would shed its manufacturing unit, which has a focus on cell and gene therapies. And, according to its CEO Birgit Girshick, other companies are likely considering doing the same thing.

Raccontata daendpoints.news